Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Winfastorlose who wrote (8677)	3/26/2020 10:59:30 AM
From: Clam digger	1 Recommendation Recommended By kimberley Respond to of 26459

Interesting. Thanks. Looking at the science of the in vitro studies combined with anecdotal reports certainly looks promising. Being more clinician than scientist, personally would love to see controlled studies but there are times like the present when we need to act quicker than what conventional clinical practice would otherwise have us do.

To: Winfastorlose who wrote (8677)	3/26/2020 12:29:41 PM
From: Kirk ©	1 Recommendation Recommended By Winfastorlose Respond to of 26459

This is FANTASTIC news for getting the economy up and running quickly.. "Pass the Test - Go back to Work and you can eat in restaurants again!" mlo-online.com Diazyme Laboratories announce availability of COVID-19 antibody tests Mar 26th, 2020 Courtesy of Pexels Diazyme announced the availability of two serological tests for the novel coronavirus (SARS-CoV-2) – the Diazyme DZ-Lite SARS-CoV-2 IgG and the SARS-CoV-2 IgM CLIA test kits. The Diazyme IgG and IgM tests run on the fully automated Diazyme DZ-Lite 3000 Plus chemiluminescence analyzer. The Food and Drug Administration (FDA) recently issued a guidance, allowing commercial manufacturers to begin distributing tests for detecting SARS-CoV-2 before those products receive an emergency use authorization (EUA) from the FDA. “Research has shown that after infection with SARS-CoV-2, viral antigens stimulate the body’s immune system to produce antibodies that can be detected with our IgM and IgG tests. The fully automated serological tests that we provide have high specificity, sensitivity and clinical agreement with samples confirmed with the standard nucleic acid testing method (RT-qPCR)" said Chong Yuan, PhD, managing director of Diazyme Laboratories, a Poway, CA-based life science affiliate of General Atomics.